Molina Healthcare, Inc. (MOH) — Financial statements
Income statement, balance sheet, and cash flow for Molina Healthcare, Inc. — annual and quarterly history with growth and margin analysis.
| Metric (USD Millions) | 2025 | 2024 | 2023 | 2022 | 2021 | |
|---|---|---|---|---|---|---|
| Revenue & Gross Profit | ||||||
| Revenue | 45,426↑11.7% | 40,650↑19.3% | 34,072↑6.6% | 31,974↑15.1% | 27,771 | |
| Cost of Revenue | 41,351↑15.1% | 35,914↑20.8% | 29,738↑6.0% | 28,048↑14.5% | 24,491 | |
| Gross Profit | 4,075↓14.0% | 4,736↑9.3% | 4,334↑10.4% | 3,926↑19.7% | 3,280 | |
| Operating Expenses | ||||||
| R&D Expenses | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| General & Administrative Expenses | 3,009↑9.7% | 2,743↑11.4% | 2,462↑6.5% | 2,311↑11.8% | 2,068 | |
| Selling & Marketing Expenses | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| SG&A Expenses | 3,009↑9.7% | 2,743↑11.4% | 2,462↑6.5% | 2,311↑11.8% | 2,068 | |
| Other Expenses | 285↓0.3% | 286↓4.3% | 299↓32.4% | 442↑130.2% | 192 | |
| Operating Expenses | 3,294↑8.7% | 3,029↑9.7% | 2,761↑0.3% | 2,753↑21.8% | 2,260 | |
| Total Costs & Expenses | 44,645↑14.6% | 38,943↑19.8% | 32,499↑5.5% | 30,801↑15.1% | 26,751 | |
| Operating Results | ||||||
| Operating Income | 781↓54.2% | 1,707↑8.5% | 1,573↑34.1% | 1,173↑15.0% | 1,020 | |
| Depreciation & Amortization | 195↑4.8% | 186↑8.8% | 171↓2.8% | 176↑34.4% | 131 | |
| EBITDA | 976↓48.4% | 1,893↑8.5% | 1,744↑29.3% | 1,349↑19.8% | 1,126 | |
| EBIT | 781↓54.2% | 1,707↑8.5% | 1,573↑34.1% | 1,173↑17.9% | 995 | |
| Interest & Other Income | ||||||
| Net Interest Income | -192↓62.7% | -118↓8.3% | -109↑0.9% | -110↑8.3% | -120 | |
| Interest Income | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Interest Expense | 192↑62.7% | 118↑8.3% | 109↓0.9% | 110↓8.3% | 120 | |
| Non-Operating Income | 0.00 | 0.00 | 0.00 | 0.00↓100.0% | 25 | |
| Other Income / Expenses | -192↓62.7% | -118↓8.3% | -109↑0.9% | -110↑24.1% | -145 | |
| Income Before Tax | 589↓62.9% | 1,589↑8.5% | 1,464↑37.7% | 1,063↑21.5% | 875 | |
| Income Tax Expense | 117↓71.5% | 410↑9.9% | 373↑37.6% | 271↑25.5% | 216 | |
| Net Income & EPS | ||||||
| Net Income from Continuing Operations | 472↓60.0% | 1,179↑8.1% | 1,091↑37.8% | 792↑20.2% | 659 | |
| Net Income from Discontinued Operations | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Net Income | 472↓60.0% | 1,179↑8.1% | 1,091↑37.8% | 792↑20.2% | 659 | |
| Bottom-Line Net Income | 472↓60.0% | 1,179↑8.1% | 1,091↑37.8% | 792↑20.2% | 659 | |
| EPS (Basic) | 8.93↓56.5% | 20.52↑9.7% | 18.71↑36.6% | 13.70↑20.2% | 11.40 | |
| EPS (Diluted) | 8.92↓56.3% | 20.42↑8.7% | 18.78↑38.7% | 13.54↑20.4% | 11.25 | |
| Weighted Average Shares | 51↓11.5% | 57↓1.2% | 58↑0.5% | 58↑0.0% | 58 | |
| Weighted Average Diluted Shares | 51↓12.0% | 58↓0.7% | 58↓0.7% | 59↓0.2% | 59 | |
* All figures in Millions of USD, except per share data. Growth rates calculated Year-over-Year (YoY). Data source: SEC Filings.